Keyphrases
AIDS/HIV
10%
Antibody Test
10%
Atorvastatin
28%
Birth Weight
11%
Bleeding
8%
Cardiovascular Risk
14%
Cesarean Section (C-section)
10%
Chest X-ray
9%
Clinical Pregnancy
8%
COVID-19
55%
COVID-19 Infection
12%
Early Onset
17%
Early-onset Preeclampsia
12%
Endothelial Activation
8%
Fetal Growth Restriction
8%
Hypertension
15%
Indonesia
32%
Indonesian
9%
Inflammatory Cytokines
9%
Late-onset
12%
Late-onset Preeclampsia
12%
Magnesium Sulfate
21%
Maternal Death
15%
Maternal Outcomes
30%
Maternal Serum
9%
Maternal-neonatal
9%
Neonatal Morbidity
13%
Neonatal Mortality
9%
Neonatal Outcome
15%
Normal Pregnancy
10%
Obstetrics
13%
Oligohydramnios
8%
Perinatal Outcome
26%
Placenta Accreta
8%
Placenta Accreta Spectrum
14%
Placental Growth Factor (PlGF)
14%
Preeclampsia
100%
Preeclampsia Prevention
9%
Pregnancy Outcome
13%
Pregnant Women
50%
Quantitative PCR
12%
Rapid Antigen Test
16%
Referral Hospital
8%
Retrospective Cohort Study
11%
Selective Intrauterine Growth Restriction (sIUGR)
8%
Serum Levels
24%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
35%
Surabaya
36%
Systematic Meta-analysis
14%
Tertiary Care Hospital
8%
Medicine and Dentistry
Birth Weight
8%
Bleeding
9%
Body Mass Index
9%
Cardiovascular Disease
7%
Cardiovascular Risk
14%
Cesarean Section
15%
Cohort Analysis
8%
COVID-19
52%
Diseases
11%
Double Outlet Right Ventricle
7%
Eclampsia
7%
Eisenmenger's Syndrome
7%
Fetus Growth
14%
Gestational Age
9%
Gestational Hypertension
8%
Gestational Weight Gain
7%
Health Care
7%
Human Immunodeficiency Virus
11%
Hysterectomy
7%
Immunoassay
16%
Infection
12%
Low Birth Weight
9%
Magnesium
7%
Magnesium Sulfate
21%
Maternal Death
22%
Maternal Mortality
7%
Mesenchymal Stem Cell
7%
Meta-Analysis
21%
Metabolic Syndrome
11%
Neuroprotection
7%
Newborn Morbidity
10%
Newborn Mortality
11%
Obstetric Emergency
14%
Obstetrics
16%
Patient Referral
15%
Placenta
9%
Placenta Accreta
17%
Polypharmacy
7%
Pravastatin
7%
Pre-Eclampsia
69%
Pregnancy
12%
Premature Labor
17%
Protein Tyrosine Kinase
7%
Randomized Controlled Trial
10%
Retrospective Cohort Study
10%
Screening
7%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Spectrum Disorder
7%
Systematic Review
24%
Tumor Necrosis Factor
7%